Email piyush.patel@visiongain.com for early bird discount

1. CALL
NOW FOR
EARLY BIRD
Drug Delivery Systems
DISCOUNTS
Americas 2011
Examining latest scientific research, manufacturing and commercial opportunities
November 16th - 17th 2011, Boston, USA BOOK NOW!
Key Speakers
Anand Subramony, Principal Fellow & Head Novel Delivery Technologies & Therapeutics,
Novartis
Avinash G. Thombre, Research Fellow, Pfizer
Bernhardt L. Trout, Director, Novartis-MIT Center for Continuous Manufacturing
Danchen Gao, Director of Intellectual Property Strategy, Abbott
Joseph Wong, Principal Scientist, Baxter
Kathleen L. Hefferon, Professor, University of Toronto
Lee Shorter, Director R&D Open Innovation, GlaxoSmithKline
Niren Murthy, Associate Professor, Georgia Institute of Technology
Oliver Steinbach, Senior Director, Head Bio-Molecular Engineering, Philips
Corporate Technologies
Otilia Koo, Senior Research Investigator, Drug Product Science & Technology,
Bristol-Myers Squibb
Peter Hoffmann, VP New Technology Development, Genzyme
Riccardo Panicucci, Head of Chemical & Pharmaceutical Profiling, Novartis
Saileta Prabhu, Scientist, Genetech
Z. Jane Li, Senior. Research Fellow, Boehringer-Ingelheim
Driving the Industry Forward | www.futurepharmaus.com
Media Partners Organised By
To Book Call: +44 (0) 20 7336 6100 | www.visiongain.com/ddsamericas

2. Conference Introduction
Drug Delivery Systems Americas
November 16th - 17th 2011, Boston, USA
Dear Colleague,
orth $93.60bn in 20091, drug delivery technology and systems is one
W Poster Presentation
of the fastest growing markets in the pharmaceutical and biotechnology At a busy conference it is hard to make sure everyone
who shares your interests knows what you are doing.
sectors with almost 50% of the revenue generated from North America . 2
Maximise your time at Visiongain’s Biosimilars and Follow-
This sector is expected to maintain double digit growth in the coming years On Biologics Americas meeting by sharing your results in a
poster presentation. With a plethora of key decision makers,
which will depend on new and innovative developments in drug delivery take advantage of this senior networking opportunity.
technology that offer improved clinical advantages, patient comfort, Please send your 200 word abstract, in English, to:
convenience and compliance. info@visiongainglobal.com for approval. The deadline
for submissions is Friday, November 4th, 2011. Please
rug Delivery Systems Americas 2011 - building on the success of our
D include contact details for the corresponding author(s).
previous six drug delivery conferences will bring together industry experts Academic institutions will not be charged a fee if booked as
full-price delegates. Posters submitted by pharmaceutical
from around the world to discuss the crucial issues and current trends and biotechnology firms will be charged a fee of £199
in drug delivery systems. This two day event will focus on various drug (USD $319*).
formulations, delivery of lipids, proteins and peptides additionally exploring Posters submitted by service providers / vendors are
welcome and will be subject to evaluation. Upon approval
drug delivery commercial aspects, partnering and out-sourcing, key a fee of £500 (USD $801*) will apply. Two delegates from
your organisation must be booked at full price to present
regulatory and legal issues. a poster.
Please note that all posters will be displayed at the
Attendance at this conference will enable you to: discretion of Visiongain Ltd and are subject to approval.
Due to limited space, please register your interest early.
• vercome challenges and opportunities in the delivery of small molecules
O
• ain insight about protein and peptide drug delivery strategies for product
G
lifecycle management Who should attend this conference?
• xplore innovations in generic development of drug delivery systems
E VPs, Directors, Heads, Managers of:
• Pharmaceutical Development
• Discuss about enhancing the bioavailability of poorly soluble drugs • Drug Delivery
• Delivery Device Development
• Learn impact on product lifecycles: controlled-release technologies • Product Development
• Analytical Chemistry
• Evaluate niosomes as effective transdermal drug delivery systems • Pre-formulation
• Project Management
• Discover advances in oral transmucosal drug delivery • Technology Development
• Drug Delivery Partnering
• Stay ahead by learning latest on biologics delivery systems • Out-sourcing
• In-Licensing
• Identify different strategies in managing a drug delivery alliance • Technology Assessment
• Lifecycle management
• Examine PTD–DRBD siRNA Delivery • Strategic Planning and Development
• Formulation/Stability
• Obtain latest information on ultrasonic drug delivery • Business Development
• Licensing
• Create patient centered drug delivery product • Commercial Development
• Patents
• ind out information on regulations and current practices nasal drug products
F • Lifecycle Management
• Strategic Planning and Development
• eview advanced technological and regulatory developments on QbD/PAT
R • Financial Analyst
in Pharmaceutical development • Pharmaceutical and Analytical R&D
• Testing
• revent aggregation in manufacturing and formulation of protein and
P • New Product Planning
• New Technology Evaluation
peptide therapeutics • Marketing
• Brand Management
• btain the latest market analysis, and meet manufacturers showcasing
O • Product Management
• Sales
their leading products
• Regulatory Affairs
I look forward to meeting you at the conference Others:
• Intellectual Property Attorneys
Best regards • Venture Capitalists
• Medical Device Companies
• Analysts/Investment Banks
• CROs
• Contract Sales Organisations
• Universities and Government Research
• Testing and Manufacturing Equipment
Sonia Tomar • Packaging Companies
Conference Producer
*USD price is estimate only
1
visiongain’s Drug Delivery technologies: Commercial prospects 2010-2025
2
MarketsandMarkets: Top 10 Drug Delivery Technologies Market to be US$156 Billion by 2015

3. Day 1
Drug Delivery Systems Americas
Wednesday November 16th 2011
09:00 Registration and refreshments 14:20 Life-cycle management: development and
manufacturing process considerations for fixed-dose
09:30 Opening address from the chair combination drug products
• aterial powder and mechanical properties considerations that impact
M
09:40 The magic bullets of the shots heard round the the processibility and quantity of fixed-dose combination products
world targeted macromolecule delivery • echnologies to monitor process and product quality, as well as to
T
• Obtain overview of the option to deliver biologics to target manage risks
• Stimulate use advanced drug delivery formulation for targeting
• ontrol systems that can improve scale-up and manufacturing
C
• Enable macromolecules targeting to treat
• Identify state of the art targeting delivery options Otilia Koo
Senior Research Investigator, Drug Product Science & Technology
Peter Hoffmann
Bristol-Myers Squibb
VP New Technology Development
Genzyme Pharmaceuticals
15:00 Afternoon Refreshments
10:20 Emerging drug delivery technologies towards
patient centric therapy 15:20 The mucosal response to plant-derived
• Delivery of high volume biologics/antibodies: biopharmaceuticals
• atch pumps devices as an emerging alternative to subcutaneous
P • iopharmaceuticals can be produced quickly and inexpensively in plants
B
injections for the delivery of biologics • onsumption of vaccines proteins via edible plant tissues has been
C
• Use of mechanical and electromechanical systems demonstrated to effectively elicit a mucosal immune response
• Creating patient centric drug delivery tools via user studies
• lants have advantages as bioreactors because unlike bacterial systems,
P
• Microneedles and the trandermal interface
they possess post-translational machinery, and unlike mammalian cell
• Programmable drug delivery methods
culture systems, they are free from infectious contaminants
Anand Subramony
Principal Fellow and Head • lant-derived biopharmaceuticals have enormous potential for assisting
P
Novartis vaccination programs in developing countries, for the prevention of global
pandemics/ bioterrorism, and for applications in personalized medicine
11:00 Morning refreshments • number of plant derived biopharmaceuticals have completed clinical
A
trials and have now entered the global marketplace
11:20 Overcome challenges and opportunities in the Kathleen L. Hefferon
Professor
delivery of small molecules
University of Toronto
• Fundamentals of delivery of small molecules
• Controlled release in delivery of proteins and nucleic acids
• nalysing intestinal solubility and permeability and particle size to
A 16:00 Addressing delivery of antibodies across the blood-
overcome rate limited absorption brain barrier (BBB)
Z. Jane Li • Overview of the transport barriers for antibodies in the brain
Senior Research Fellow
• Disposition of antibodies in the CNS
Boehringer-Ingelheim
• Leveraging receptor-mediated transcytosis for CNS delivery
12:00 Development and administration of intravenous Saileta Prabhu
Scientist
nanosuspension
Genetech
• here has been growing interest in nanoparticles as an approach to
T
formulate poorly soluble drugs
• his presentation provides an insight into various challenges associated with
T 16:40 Closing remarks from the chair
developing and administrating intravenous nanosuspension including:
• formulation approach of stabilizing nanosuspension
A 16:50 Networking Drinks
• article size and nanosuspension sterility considerations
P Take your discussions further and build new
• re-clinical disposition of a nanosuspension following IV administration
P relationships in a relaxed and informal setting.
• nfusion rates for nanosuspension
I
Joseph Wong
Principal Scientist
Baxter
N
EW
Pharma Business Daily
SL
12:40 Networking lunch
E
Each issue of Pharma Business Daily newsletter focuses on latest
TT
ER
breaking stories in your market. Delivered directly to your Inbox or
13:40 Life cycle management through drug available through the website, all the industry news is available to
delivery technologies you all the time. When you want the news its there for you - it really
is that simple. Over 25+ stories everyday as they happen. Never again
• Challenges and opportunities in life cycle management
will any of your colleagues be aware of news that you aren’t. Plus
• Product enhancement using drug delivery exclusive features from visiongain conferences and in-depth analysis
• Platform controlled release technologies from visiongain analysts will be available to you thanks to your
• Case studies and lessons learned subscription to PharmaBusinessDaily. This information is not available
Avinash G. Thombre anywhere else.
Research Fellow Call +44 (0)207 336 6100 or visit www.visiongain.com to sign up.
Pfizer
Due to unforeseen circumstances the programme may change and visiongain reserves the right to alter the venue and/or speakers c Copyright visiongain Ltd, 2011

4. Day 2
Drug Delivery Systems Americas
Thursday November 17th 2011
09:00 Registration and refreshments 12:40 Networking lunch
09:30 Opening address from the chair 13:40 Prevent aggregation in manufacturing and formula-
tion of protein and peptide therapeutics
• Techniques to predict aggregation propensity
09:40 New materials for drug delivery and • New approaches to preventing aggregation
molecular imaging • A strategy for developability and manufacturability early on
• Overview on new materials for drug delivery
• Ways to design molecules for stability
• Autocatalytic drug delivery vehincles
Bernhardt L. Trout
• Polyketals : a new biomaterial for drug delivery Director, Novartis-MIT Center for Continuous Manufacturing
• Oral siRNA delivery vehicles Professor, Department of Chemical Engineering,
Massachusetts Institute of Technology
Niren Murthy
Associate Professor
Georgia Institute of Technology
14:10 Finding synergy in drug delivery through
strategic outsourcing
10:20 IMAG(IN)E global - release local – Image-guided • The value of strategic outsourcing: decision drivers
ultra sound-triggered drug delivery • From transactional to strategic
• edical imaging technologies are becoming an integral part of
M • Strategic outsourcing: what lies ahead
therapeutic interventions
Danchen Gao
• he development of ultrasound techniques that could non-invasively
T Director of Intellectual Property Strategy
trigger the delivery of also very new drug formats such as RNAi Abbott
therapeutics at a targeted location opens up exciting possibilities for
advancing personalized medicine
• key success factor for the effective translation of new drug delivery
A 15:00 Afternoon refreshments
concepts into clinical practice are partnerships with leading academic,
medical institutions and industrial partners
• hilips’ image-guided ultrasound-mediated drug delivery platform offers
P
15:20 Open Innovation in preclinical development at
researchers a unique approach to investigating the delivery of various
GSK pharmaceuticals
therapeutic molecules and capitalizes upon Philips’ existing expertise
in medical imaging technologies for diagnosis, therapy planning and • What is open innovation?
minimally-invasive medical procedures • hy is GSK using open innovation within the platform technology and
W
• e show advances in temperature sensitive liposomes with incorporated
W Science group?
drugs and MRI-imaging labels as well as pressure-sensitive microbubbles • Process GSK PTS is following for open innovation
with specific ultrasound-imaging and drug release characteristics for the
• Examples of successful open innovation collaborations
local delivery of small molecule- and nucleic-acid based therapeutics
including siRNA • How will success of open innovation be measured?
Oliver Steinbach Lee Shorter
Senior Director, Head Bio-Molecular Engineering Director R&D Open Innovation
Philips Corporate Technologies GlaxoSmithKline
11:00 Morning refreshments 16:00 Patent and other Intellectual property rights in
drug delivery
• Advancements in drug delivery technology
11:20 Sponsor Spotlight Session • Patenting the technological advancements
T
ake this unique opportunity to be a part of the conference • Issues around manufacturing process patents
theme, network, share ideas and provide an overview of your • ntellectual property protection, such as trade secrets, copyrights,
I
product/services to the audience. For more information please and trademarks
contact damian.gorman@visiongainglobal.com
16:40 Chair’s closing remarks
12:00 Presentation to be announced
Riccardo Panicucci
Head of Chemical & Pharmaceutical Profiling 16:50 End of Conference
Novartis

5. Partners
Drug Delivery Systems Americas
November 16th - 17th 2011, Boston, USA
Media Partners:
PharmiWeb.com is the leading industry-sponsored Sponsorship and exhibition opportunities:
portal for the pharmaceutical sector. Supported This event offers a unique opportunity to meet and do business
by most of the leading pharmaceutical corporations, PharmiWeb.
with some of the key players in the pharmaceutical and biotech
com provides dynamic real-time news, features, events listings and
international jobs to industry professionals across Europe and the US. industries. If you have a service or product to promote, you can
For further information please email: corporate@pharmiweb.com do so at this event by:
• Hosting a networking drinks reception
BIOTECHNOLOGY EUROPE is owned by
• Taking an exhibition space at the conference
BIOTECHNOLOGY WORLD. It is based and located
in Warsaw, Poland. Biotechnology World was founded in 2007 to • Advertising in the delegate documentation pack
provide the world’s biotech and pharma information and market to
• Providing branded bags, pens, gifts, etc.
make it universally accessible and useful for scientific and business
processes. Its first step to fulfilling that mission was building the If you would like more information on the range of
BIOTECHNOLOGY EUROPE platform that will allow a quick spread of
sponsorship or exhibition possibilities for visiongain's
information in different channels. BIOTECHNOLOGY EUROPE offers
companies completed internet public relations, publication and Drug Delivery Systems Americas Conference,
marketing solutions. One of the mains goals of BIOTECHNOLOGY please contact us.
EUROPE is to integrate the Biotech and Pharma Sector in Europe to
Damian Gorman, +44 (0)20 7549 9934
global biotechnology, pharmaceutical and life science activities.
For further information please visit www.biotechnology-europe.com damian.gorman@visiongainglobal.com
InPharm is the online platform for exclusive
pharmaceutical news, comment, contracts, services,
jobs and events and is home to InPharmjobs.com, Pharmafile and About visiongain:
Pharmafocus. Visiongain is a specialist business information company focused on
For further information please visit: www.inpharm.com
providing cutting edge products and services across the Pharmaceutical/
Biotech, Telecommunications, Defence and Finance sectors, which
Future Pharmaceuticals has forged powerful
Driving the Industry Forward | www.futurepharmaus.com include reports, conferences, online daily news and offline news
relationships with key industry leaders to provide analysis and bespoke consultancy. With a commitment to innovation
a platform for successful brand recognition, and for senior decision-
and excellence, visiongain offers flexible solutions to meet our clients’
makers to have the means to procure and plan implementation
business intelligence needs, providing the right information at the
strategies based on the topics covered. Positioned to be an
authoritative resource within top pharma companies as well as small, right time to facilitate the commercial decision-making process. Our
specialty, and biotech, Future Pharmaceuticals magazine is geared pharmaceutical products include Pharma Business Daily, the leading
to create a deep penetration into a highly targeted and responsive daily email newsletter for the pharmaceutical, biotech and healthcare
audience, bridging the gap between the industries’ top issues and
industries, and a range of independent, high-quality, in-depth reports
the solutions top-tier vendors can provide.
covering focused and topical areas of concern. Our pharmaceutical
For further information please visit: www.futurepharmaus.com
conferences address the hottest commercial, regulatory and technical
topics and provide an ideal forum for debate and networking for
pharmaceutical professionals from around the world.
For further information, please visit: www.visiongain.com

6. Registration Form
Drug Delivery Systems Americas
November 16th - 17th 2011, Boston, USA
Conf. code PP
Standard Prices
Conference only Fee: £1299 (USD* 2081)
Drug Delivery Systems Americas
November 16th - 17th 2011
Number of bookings: Total cost: Boston, USA
*USD price is estimate only
Promotional Literature Distribution
Distribution of your company’s promotional literature to all conference attendees
Fee: £999 VAT: £199.80 Total: £1198.80
How to book
Details
Email: piyush.patel@visiongain.com
Forename: Surname: Web: http://www.visiongain.com/ddsamericas
UK Office:
Job Title: Company: Tel: +44(0) 20 7549 9961
Fax: +44(0) 20 7549 9932
Main Switchboard Number: Visiongain Ltd
230 City Road
London
Address: EC1V 2QY
UK
General information
Venue: TBA, Boston, USA
Country: Postcode:
Payment terms: Visiongain require the full amount to be paid before the conference. Visiongain
Ltd may refuse entry to delegates who have not paid their invoice in full. A credit card guarantee
Phone: Fax: may be requested if payment has not been received in full before the event. Visiongain Ltd reserves
the right to charge interest on unpaid invoices.
Email: Substitutions/name changes or cancellations: There is a 50% liability on all bookings once
made, whether by post, fax, email or web. There is a no refund policy for cancellations received on or
Signature: after one month before the start of the event. Should you decide to cancel after this date, the full invoice
must be paid. Conference notes will then be sent to you. Unfortunately, we are unable to transfer places
I confirm that I have read and agree to the terms and conditions of booking between conferences. However, if you cannot attend the conference, you may make a substitution/name
change at any time, as long as we are informed in writing by email, fax or post. Name changes and
substitutions must be from the same company or organisation and are not transferable between
Methods of payment countries. Please note that discounted delegates places at a visiongain event are non refundable.
Payment must be made in sterling Invoice alterations: There will be an administration charge of £50 for any changes to an invoice,
excluding substitutions/name changes, requested by the customer. This will be charged to the
By Mail: Complete and return your signed registration form together with your cheque payable customer by credit card prior to the changes being made.
to Visiongain Ltd and send to: visiongain Ltd, BSG House, 226-236 City Road, London, EC1V 2QY, UK Indemnity: Visiongain Ltd reserves the right to make alterations to the conference/executive
briefing content, timing, speakers or venue without notice. The event may be postponed or cancelled
By Fax: Complete and fax your signed registration form with your credit card details due to unforeseen events beyond the control of visiongain Ltd. If such a situation arises, we will try
to +44 (0) 20 7549 9932 to reschedule the event. However, visiongain Ltd cannot be held responsible for any cost, damage or
expenses, which may be incurred by the customer as a consequence of the event being postponed or
By Phone: Call us on +44 (0) 20 7336 6100 with your credit card details cancelled. We therefore strongly advise all our conference clients to take out insurance to cover the
cost of the registration, travel and expenses.
By Credit Card: Fill in your card details below and fax back to +44 (0) 20 7549 9932
Data Protection: Visiongain Ltd gathers and manages data in accordance with the Data
By Bank Transfer: Protection Act 1988. Your personal information contained in this form may be used to update you on
visiongain Ltd products and services via post, telephone, fax or email, unless you state otherwise. We
Visiongain Ltd A/C: visiongain Ltd may also share your data with external companies offering complementary products or services. If you
Barclays Bank Sort Code: 20-71-64 wish for your details to be amended, suppressed or not passed on to any external third party, please
Piccadilly Branch Account No: 6038 7118 send your request to the Database Manager, visiongain Ltd, BSG House, 226-236 City Road, London,
EC1V 2QY. Alternatively, you can visit our website at www.visiongain.com and amend your details.
48 Regent Street Swift Code: BARC GB22 Please allow approximately 30 days for your removal or update request to be applied to our database.
London W1B 5RA, UK IBAN: GB80 BARC 20716460387118 Following your removal or update request, you may receive additional pieces of communication from
visiongain Ltd during the transitional period, whilst the changes are coming into effect.
Please debit my credit card: Fee: The conference fee includes lunch, refreshments and conference papers provided on the day.
Access MasterCard Visa American Express This fee does not include travel, hotel accommodation, transfers or insurance, (which we strongly
recommend you obtain).
VAT: VAT will be charged at the local rate on each conference. Delegates may be able to recover VAT
Card number: incurred by contacting Eurocash Corporation plc +44 (0) 1273 325000, eurocash@eurocashvat.com.
Eurocash specialise in recovering cross-border VAT.
How we will contact you: Visiongain Ltd’s preferred method of communication is by email and
phone. Please ensure that you complete the registration form in full so that we can contact you.
Expiry Date:
Unable to attend
Security number (last 3 digits on back of credit card): Obviously nothing compares to being there but you need not miss out. Simply tick the box and send
with your payment. You will receive speaker talks in PDFs two weeks after the event.
Signature: Yes, please send me speaker talks Price£550 VAT:£110 Total:£660
Cardholder’s name: Office use only
News updates
Please tick if you do not want to receive email news updates in the future
www.visiongain.com/ddsamericas